Funding, News and Announcements
» Go to news mainPfizer Junior Investigator Global ATTR Amyloidosis Research ASPIRE
This competitive grant program seeks to support research conducted by Junior Investigators that advances medical knowledge in the understanding, diagnosis, and treatment of ATTR Amyloidosis through research focused in the following areas:
- Epidemiologic evaluations for ATTR amyloidosis
- Approaches for the early identification and follow up of ATTR amyloidosis patients
- RW efficacy and safety of tafamidis in the clinical setting for the management of ATTR amyloidosis
- Evaluation of patients with ATTR-CM presenting with a mixed phenotype (e.g. cardiomyopathy and polyneuropathy)
- Pathophysiology
Individual projects requesting up to $75,000 USD/year for 1 to 2 years will be considered.
Click here for full details about this call [PDF].
Deadlines
Internal: March 7, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.
Funder: March 21, 2023. Contact email is amanda.j.stein@pfizer.com.
Recent News
- Canada Foundation for Innovation
- Council of Atlantic Academic Libraries
- Operations & Maintenance Response Fund 2024
- Canada Foundation for Innovation
- Ireland Canada University Foundation: Craig Dobbin Legacy Scholarships
- United States Department of Defense new funding opportunities
- CIMVHR True Patriot Love Research Initiative
- NSERC information session